Cargando…
Therapeutic strategies against cancer stem cells in human colorectal cancer
Colorectal cancer (CRC) is the third most frequent malignancy and represents the fourth most common cause of cancer-associated mortalities in the world. Despite many advances in the treatment of CRC, the 5-year survival rate of patients with CRC remains unsatisfactory due to tumor recurrence and met...
Autores principales: | Szaryńska, Magdalena, Olejniczak, Agata, Kobiela, Jarosław, Spychalski, Piotr, Kmieć, Zbigniew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727596/ https://www.ncbi.nlm.nih.gov/pubmed/29250169 http://dx.doi.org/10.3892/ol.2017.7261 |
Ejemplares similares
-
Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer
por: Szaryńska, Magdalena, et al.
Publicado: (2018) -
Triiodothyronine lowers the potential of colorectal cancer stem cells in vitro
por: Rostkowska, Olga, et al.
Publicado: (2022) -
Proton pump inhibitors and colorectal cancer: A systematic review
por: Patel, Agastya, et al.
Publicado: (2021) -
Diversity of dendritic cells generated from umbilical cord or adult peripheral blood precursors
por: Szaryńska, Magdalena, et al.
Publicado: (2018) -
Adenoma to Colorectal Cancer Estimated Transition Rates Stratified by BMI Categories—A Cross-Sectional Analysis of Asymptomatic Individuals from Screening Colonoscopy Program
por: Spychalski, Piotr, et al.
Publicado: (2021)